[HTML] mdpi.com

[HTML][HTML] Ultrastructure in transthyretin amyloidosis: from pathophysiology to therapeutic insights

H Koike, M Katsuno - Biomedicines, 2019 - mdpi.com
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …
被引用次数：73 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights

H Koike, M Katsuno - pdfs.semanticscholar.org
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights

H Koike, M Katsuno - Biomedicines, 2019 - cir.nii.ac.jp
抄録< jats: p> Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type
or variant amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights

H Koike, M Katsuno - Biomedicines, 2019 - pubmed.ncbi.nlm.nih.gov
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …
[HTML] nih.gov

[HTML][HTML] Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights

H Koike, M Katsuno - Biomedicines, 2019 - ncbi.nlm.nih.gov
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights

H Koike, M Katsuno - 2019 - agris.fao.org
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.

H Koike, M Katsuno - Biomedicines, 2019 - europepmc.org
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.

H Koike, M Katsuno - Biomedicines, 2019 - search.ebscohost.com
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights

M Katsuno - Biomedicines, 2019 - search.proquest.com
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …

Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.

H Koike, M Katsuno - Biomedicines, 2019 - europepmc.org
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant
amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has …